CRISPR, the gene-editing technology which won its creators the 2020 Nobel Prize for Chemistry, is most well-known for its ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...

Cambridge-based Fulcrum Therapeutics said it will aim to launch a large clinical trial in the second half of 2026 to prove ...

CRISPR Therapeutics AG (CRSP) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...

A recent study in the journal PNAS from the lab of Julie Overbaugh reveals a previously unknown antiviral function of a gene ...

Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

A groundbreaking new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) ...

A team of researchers at the Icahn School of Medicine at Mount Sinai has uncovered why children with the same ...

The genetically engineered food is also protein packed and sustainable, say scientists. Chinese researchers used gene-editing ...

Penn Medicine shows how sustained research investment drives innovation, economic growth, and global health breakthroughs.

Poster presentation highlights promising results from Phase 1b/2 TENACITY-01 study of CTD402 in T-Cell and myeloid leukemiasFindings underscore ...

A cutting-edge base-edited CAR T-cell therapy is opening a revolutionary new frontier for patients battling aggressive T-cell leukemia.